Commercial Agreement Sends Micro Cap Soaring

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, April 19, 2023

A Calgary-based healthcare company is stealing the spotlight so far during Wednesday’s session after an announcement came out after hours Tuesday detailing the execution of a commercial agreement with Sandhill One, LLC. According to the release, upon completion of its development project with Sandhill and assuming the optimized enzyme is utilized in Sandhill's end-market manufacture, following receipt of milestone payments, it may receive a reasonably significant percent of Sandhill's end-market revenues.

Shares of Willow Biosciences Inc. (TSX:WLLW) (OTCQB:CANSF) were launched at the open as traders pushed the share price up to $0.17/share (+21.43%) at the early session high. This move was a strong continuation of the success this stock has had over the last few weeks.

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.